Form 4: Vaxcyte Director Halley Gilbert Exercises Options and Sells Shares Under 10b5-1 Plan

Director Halley Gilbert exercised stock options and sold shares of Vaxcyte, Inc. under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On June 3, 2024, Halley E. Gilbert, a director of Vaxcyte, Inc. [PCVX], exercised stock options to acquire 18,200 shares of common stock at a price of $5.35 per share.
• On the same day, Gilbert sold 18,200 shares of common stock at $73 per share.
• These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 1, 2024.
• Following these transactions, Gilbert directly owns 5,625 shares of Vaxcyte common stock.
• Gilbert also transferred 30,374 vested stock options to an ex-spouse due to a domestic relations order and will no longer report these options.

Sentiment

Score: 5

Explanation: Neutral sentiment as the transactions are part of a pre-planned trading strategy and do not necessarily reflect a change in the director's outlook on the company.

Positives

• The exercise of options and subsequent sale of shares indicates that the director is converting potential value into realized value.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions of key personnel.

Related Party Transactions

• Transfer of 30,374 vested stock options to ex-spouse pursuant to a domestic relations order.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the sale of shares in the open market.

Key Dates